Krebs Biochemicals and Industries Reports Q1 Results; Board Approves Amalgamation with Ipca Laboratories
Krebs Biochemicals and Industries Limited has released its unaudited financial results for the first quarter ended June 30, 2026. The company’s Board of Directors approved these findings at a meeting held on August 6, 2026, along with reviewing an auditor's limited review report.The company reported that its operations are currently confined to one segment, and no subsidiary or associate companies were noted as of June 30, 2026. Financially, the company recorded a net loss for the quarter, while simultaneously moving forward with significant strategic restructuring.
Financial Performance Snapshot (Q1 FY26)
The unaudited results reflect the challenging operational environment for the firm. Key financial metrics for the quarter ended June 30, 2026, are summarized below. All figures are in rupees in lacs.| Particulars | Q1 Ended June 30, 2026 (Unaudited) | Q1 Ended March 31, 2026 (Audited)* |
|---|---|---|
| Revenue from Operations | 698.35 | 680.91 |
| Other Income Total Income | 714.00 | 881.27 |
| Total Expenses | 962.48 | 1,115.23 |
| Profit / (Loss) before Tax | (248.48) | (233.96) |
| Net Worth | 2,156.06 | N/A |
| Basic Earnings Per Share | (1.15) | (1.09) |
Note: The figures for the quarter ended March 31, 2026 are balancing figures derived from audited data of the full financial year 2025-26.
Operational and Strategic Updates
The Board of Directors disclosed several material operational status points:Amalgamation Approval:
At its meeting held on June 26, 2026, the Board approved the amalgamation of Krebs Biochemicals & Industries Limited with Ipca Laboratories Limited. The appointed date for this scheme of amalgamation is April 1, 2026.
Manufacturing Unit Status:
The company confirmed that the operations at its Vizag manufacturing unit remain closed. This status follows an order dated February 7, 2025, issued by the Andhra Pradesh Pollution Control Board. The management has undertaken steps and is in ongoing dialogue with the Polluation Control Board regarding the revocation of the closure order.
The unaudited results were reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on August 6, 2026.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.